Literature DB >> 11455210

Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis.

D Ribatti1, B Nico, L Morbidelli, S Donnini, M Ziche, A Vacca, L Roncali, M Presta.   

Abstract

Fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF) exert their angiogenic activity by interacting with endothelial cells in a distinct manner. In this study, we investigated the morphological features of endothelial cells of the chick embryo chorioallantoic membrane (CAM) microvasculature after stimulation with FGF2 or VEGF. In order to provide a continuous delivery of the growth factor, we utilized a recently developed gelatin sponge/CAM assay in which a limited number of FGF2- or VEGF-transfected cells were adsorbed onto gelatin sponges and applied on the top of the CAM on day 8 of development. Their angiogenic activity was compared to that exerted by a single bolus of the corresponding growth factor. All the angiogenic stimuli induced a comparable vasoproliferative response, as demonstrated by the appearance of similar numbers of immature blood vessels within the sponge on day 12. No angiogenic response was observed in CAMs implanted with the corresponding parental cell lines or vehicle. Electron microscopy demonstrated that VEGF-overexpressing cells modified the phenotype of the endothelium of the blood vessels at the boundary between the implant and the surrounding CAM mesenchyme. The endothelial lining of 30% of these vessels showed segmental attenuations, was frequently interrupted and became fenestrated, mimicking what is observed in tumor vasculature. In contrast, the vessels consisted of continuous endothelium sealed by tight junctions in all the other experimental conditions. These results indicate that FGF2 and VEGF interact with endothelial cells of the CAM in a distinct manner. Both growth factors induce a potent angiogenic response, but only VEGF delivered in a continuous manner by its transfectants can modify the phenotype of the otherwise quiescent endothelium of CAM blood microvessels. The gelatin sponge/CAM assay may constitute a new model to study the mechanisms leading to endothelial fenestration in tumor growth. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455210     DOI: 10.1159/000051070

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  11 in total

1.  Vascularization of rat pituitary autografts.

Authors:  Matilde Lombardero; Andres Quintanar-Stephano; Sergio Vidal; Eva Horvath; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

2.  Vascular endothelial growth factor localization in the adult.

Authors:  Arindel S R Maharaj; Magali Saint-Geniez; Angel E Maldonado; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay.

Authors:  Marina Handel; Timo R Hammer; Patcharakamon Nooeaid; Aldo R Boccaccini; Dirk Hoefer
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

4.  Bone marrow angiogenesis and progression in multiple myeloma.

Authors:  Roberto Ria; Antonia Reale; Annunziata De Luisi; Arianna Ferrucci; Michele Moschetta; Angelo Vacca
Journal:  Am J Blood Res       Date:  2011-06-08

5.  Ultrasonic mediated synthesis of monodispersed lanthanum hydroxide nanorods for possible bioimplant application.

Authors:  Dhandapani Harini; Anantanarayanan Rajaram; Rama Rajaram
Journal:  J Mater Sci Mater Med       Date:  2015-01-20       Impact factor: 3.896

6.  G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis.

Authors:  C A Stein; Sijian Wu; Anatoliy M Voskresenskiy; Jin-Feng Zhou; Joongho Shin; Paul Miller; Naira Souleimanian; Luba Benimetskaya
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

7.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021

8.  In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane.

Authors:  Domenico Ribatti; Giuseppe De Falco; Beatrice Nico; Roberto Ria; Enrico Crivellato; Angelo Vacca
Journal:  J Anat       Date:  2003-09       Impact factor: 2.610

Review 9.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08

10.  Total Saponin from Root of Actinidia valvata Dunn Inhibits Hepatoma 22 Growth and Metastasis In Vivo by Suppression Angiogenesis.

Authors:  Guo-Yin Zheng; Hai-Liang Xin; Yan-Fen Xu; Bai Li; Xiao-Feng Zhai; Yuan-Hui Zhang; Chang-Quan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.